KOSDAQMachinery054950

Jvmco

₩24,850▲ 0.81%2026-11-18 close
Market Cap
₩300.4B
Turnover
₩200M
Volume
8.5K
Shares out.
12.1M
PER
8.6×
PBR
1.1×
EPS
₩2,952
Dividend Yield
2.57%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩650 per share · Prices as of the 2026-11-18 close

01

Report overview

High-margin North American shipments lift profitability

Jvmco lifted its third-quarter 2026 operating margin to 24.4% on high-margin North American shipments, but sales grew only 2.1% year on year, so the durability of top-line growth is the next check point.

  1. 1

    Sales have risen for three straight years since 2023, with 2025 the largest year at KRW 173.1 billion.

  2. 2

    North American sales rose 37.9% year on year in the third quarter of 2026, as higher shipments of COUNTMATE and ATDPS supported a 24.4% operating margin.

  3. 3

    Operating profit rose 8.5% in 2025, but net income attributable to controlling shareholders fell 1.7%, so the two moved in opposite directions.

  4. 4

    Net income attributable to controlling shareholders totaled KRW 34 billion over the last four quarters, and second-quarter 2026 sales of KRW 49.3 billion were reported as a record quarter.

  5. 5

    Overseas sales reached 50.8% of revenue in the second quarter of 2026, overtaking domestic sales, while raw-material supply uncertainty linked to the Middle East war remains a key variable.

02

Business structure

Jvmco designs and manufactures automated pharmaceutical dispensing equipment and is listed on KOSDAQ, with consumables sold after equipment installation forming one pillar of revenue.

Its flagship product is the ATDPS, a fully automatic tablet sorting and packaging system, while COUNTMATE, a vial-based drug counting device, was launched with North America in mind.

The robotic MENITH dispensing solution completed its first domestic customer installation in 2026 and is running at live dispensing sites, with its scope expanding toward health supplements and large dispensing markets.

In 2026 the company also introduced new products for pharmacies and hospitals, including a narcotics storage and management system.

By region, the third-quarter 2026 mix was 51.6% domestic and 48.4% overseas, with overseas sales split into Europe at 21.5%, North America at 19.1% and other regions at 7.8%, according to the preliminary release.

For full-year 2025, the split was 50% domestic and 50% export, with North America at 17%, Europe at 25% and other regions at 8%, per the preliminary filing of February 4, 2026.

An affiliate within the Hanmi Group handles overseas sales, a separate affiliate handles domestic sales, and Jvmco concentrates on R&D and production. Overseas, equipment reaches 60 countries through 35 global partner companies. In North America, McKesson Automation distributes COUNTMATE.

The Suzhou production subsidiary in China began local production and sales in the third quarter of 2026 and booked initial revenue. On the domestic market, a Sangsangin Securities analyst said in October 2025 that the market has no clear competitor and is likely to remain an oligopoly for a long time.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩39.7B₩7.6B19.1%
2025Q4₩43.1B₩5.9B13.7%
2026Q1₩45.5B₩9.3B20.4%
2026Q2₩49.3B₩13.5B27.4%
2026Q3₩40.5B₩9.9B24.4%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩142B₩22B₩15.8B15.5%10.0%46.5%
2023₩157.1B₩29.8B₩26.2B19.0%14.6%43.5%
2024₩159.4B₩30.7B₩28.8B19.2%14.3%40.8%
2025₩173.1B₩33.3B₩28.4B19.2%12.1%36.4%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-16

04

Earnings analysis

On a reported basis, annual sales rose from KRW 142 billion in 2022 to KRW 157.1 billion in 2023 (up 10.6% year on year), KRW 159.4 billion in 2024 (up 1.5%) and KRW 173.1 billion in 2025 (up 8.6%).

Sales have grown for three consecutive years from 2023 through 2025, and 2025 was the largest year in the 2022 to 2025 period.

Operating profit went from KRW 22 billion in 2022 to KRW 29.8 billion in 2023 (up 35.4%), KRW 30.7 billion in 2024 (up 3.0%) and KRW 33.3 billion in 2025 (up 8.5%), also rising for three consecutive years.

The operating margin climbed from 15.5% in 2022 to 19.0% in 2023 and then held at 19.2% in both 2024 and 2025, so most of the margin gain came in 2023.

Net income attributable to controlling shareholders jumped from KRW 15.8 billion in 2022 to KRW 26.2 billion in 2023 (up 66.6%), then reached KRW 28.8 billion in 2024 (up 9.9%) before slipping to KRW 28.4 billion in 2025 (down 1.7%).

In 2025 operating profit rose 8.5% while net income attributable to controlling shareholders fell 1.7%, so the two moved in opposite directions, and the detailed reasons should be checked in the 2026 annual report's income statement. Net income including non-controlling interests is recorded at the same yearly amounts.

Operating cash flow was KRW 14.8 billion in 2022, KRW 29.9 billion in 2023, KRW 25.9 billion in 2024 and KRW 30.4 billion in 2025.

The debt ratio fell from 46.5% in 2022 to 36.4% at the end of 2025, when total equity of KRW 233.9 billion was entirely attributable to controlling shareholders and total liabilities stood at KRW 85.2 billion.

On a quarterly basis, first-quarter 2026 sales reached KRW 45.5 billion, second-quarter sales hit KRW 49.3 billion with operating profit of KRW 13.5 billion, and third-quarter operating profit of KRW 9.91 billion was down 26.7% from the prior quarter but up 30.4% from a year earlier.

In the fourth quarter of 2025, sales of KRW 43.1 billion rose 8.5% from the prior quarter while operating profit fell 22.2% to KRW 5.91 billion, which a securities data provider put at a 14% margin.

05

Industry analysis

The automated dispensing market is supported by demand to reduce the workload of pharmacy and hospital staff. At its third-quarter 2026 results, the CEO said that dispensing environments are changing quickly and that demand for automated, robot-based systems is growing.

In the first-quarter 2026 release, the company pointed to raw-material supply instability linked to the Middle East war and said it manages the process from sourcing to production to keep supply running.

On competition, Sangsangin Securities analyst Ha Tae-gi said in an October 2025 report that the domestic market has no clear competitor and is likely to remain an oligopoly for a long time.

Overseas, the vial-based counting device COUNTMATE is sold through McKesson Automation, with sales expansion targeted in the United States and Canada.

In Europe, a partner strategy that moved France from pharmacy-focused sales to hospitals and the expansion of the sales network into Italy were linked to higher third-quarter 2025 sales in an analyst view.

In the second quarter of 2026, overseas sales reached 50.8% of the total, overtaking the domestic share of 49.2%, which strengthened the export-led structure.

Equipment sales follow the timing of installations at dispensing sites, while consumables create repeat demand after installation, so shifts in the mix between the two affect earnings stability. The company said the domestic introduction of MENITH would open paths toward health supplements and large dispensing markets.

06

Outlook

The main plans the company has outlined center on new products and wider sales channels rather than numerical targets. In an early-2026 filing, the company said it plans to launch the ATDPS DOC3 during 2026, a new model that expands manual dispensing cells from 30 to 60.

The same material said the robotic pouch-based MENITH system had completed its system upgrade, with sales expected to expand mainly in northern European countries such as the Netherlands and Germany. In the first quarter of 2026, an upgrade strengthening MENITH's inspection function was completed.

At its third-quarter 2026 release, the company said the first domestic MENITH installation would help widen business opportunities and that it would keep investing in R&D and new product launches.

The Suzhou subsidiary in China plans to stabilize local production and reorganize local partners, then serve as a production base for the Chinese market. A KRW 5 million euro operating fund will be lent to the European subsidiary JVM Europe B.V. for four years, from November 2026 through November 2030.

Of its treasury shares, 70% (387,032 shares out of 552,903) is slated for cancellation, while the remaining 165,871 shares will be used for employee stock-based compensation, with the cancellation date disclosed as November 6, 2026.

The next check points are the launch timing of DOC3 and how quickly MENITH sales in northern Europe show up in the revenue mix.

07

Valuation

PER
8.6×
PBR
1.1×
ROE
14.3%
EPS
₩2,952
BPS
₩22,182
Dividend per share
₩650

The price-to-book ratio sits in a range where the premium over book value of controlling-shareholder equity is not large. On an earnings basis, net income attributable to controlling shareholders totaling KRW 34 billion over the last four quarters serves as the reference point.

Annual net income attributable to controlling shareholders fell to KRW 28.4 billion in 2025, yet third-quarter 2026 net income attributable to controlling shareholders rose 49.9% year on year, so the earnings trend moves in different directions quarter to quarter.

Operating profit grew from KRW 22 billion in 2022 to KRW 33.3 billion in 2025, so the earnings base has widened. Quarterly operating profit swings sharply, as the 26.7% quarter-on-quarter drop in the third quarter of 2026 shows, so multiples based on single quarters can move a lot.

The decision to cancel 70% of treasury shares disclosed in 2026 reduces the number of shares outstanding. The debt ratio fell to 36.4% at the end of 2025 from 46.5% in 2022, which is a balance-sheet fact that can be read alongside the valuation.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-16

08

Bull factors

Demand for high-margin North American products

North American sales rose 37.9% year on year in the third quarter of 2026, which the company attributed mainly to higher shipments of high-profit products such as COUNTMATE and ATDPS. The same quarter's operating margin of 24.4% was reported as the highest for any third quarter. The company also cited a favorable exchange-rate environment and improved cost ratios as contributors.

Long-term gains in earnings scale and cash generation

Operating profit rose from KRW 22 billion in 2022 to KRW 33.3 billion in 2025, and operating cash flow grew from KRW 14.8 billion to KRW 30.4 billion over the same span. The debt ratio fell to 36.4% at the end of 2025 from 46.5% in 2022. A wider financial cushion supports new product development and overseas subsidiary operations.

Overseas bases and the new product pipeline

Overseas sales made up 48.4% of third-quarter 2026 revenue, split between Europe at 21.5% and North America at 19.1%. The Suzhou subsidiary began booking initial revenue in the third quarter of 2026. Sales of MENITH are expected to expand in northern Europe, and the DOC3 launch was planned for 2026.

09

Bear factors

Slowing top-line growth

Third-quarter 2026 sales of KRW 40.5 billion rose only 2.1% year on year and fell 17.8% from the prior quarter, following KRW 49.3 billion in the second quarter. Operating profit grew much faster than sales, so it is worth checking how far profit growth depends on margin factors.

Divergence between operating profit and net income

Operating profit rose 8.5% in 2025, but net income attributable to controlling shareholders fell 1.7% to KRW 28.4 billion. In the fourth quarter of 2025, operating profit fell 22.2% even though sales rose 8.5% from the prior quarter, which a securities data provider put at a 14% margin. Quarterly profit swings are large, so earnings stability needs further confirmation.

Greater exposure to external variables as overseas mix rises

Overseas sales reached 50.8% of the second quarter of 2026, overtaking the domestic share, which increases the sensitivity of quarterly results to exchange rates and partner order timing. The first-quarter 2026 release cited supply instability for raw materials linked to the Middle East war. As overseas dependence grows, the effect of such external variables grows too.

10

Risk factors

Raw materials and supply chain

Raw-material supply instability linked to the Middle East war was cited in the first-quarter 2026 release, and the company said it manages sourcing through production. If equipment and consumables are not delivered on time, the repeat demand for consumables could weaken.

The effect of raw-material price and procurement changes on cost ratios needs to be checked in quarterly figures.

Dependence on overseas partners and channels

In North America, COUNTMATE is sold through McKesson Automation, and overseas operations as a whole rely on affiliate sales channels. North American sales rose sharply in the third quarter of 2026, but quarterly revenue can swing with channel inventory and order timing. An analyst noted in 2025 that North American shipments paused for a period to work through inventory.

Currency, policy and affiliate funding

The company cited a favorable exchange-rate environment as a driver of profit gains, so profitability contributions could shift if exchange rates move. A planned 5 million euro operating loan to the European subsidiary links overseas funding to intra-group transactions. An analysis of the third quarter of 2025 pointed to a base effect from a domestic medical policy dispute.

11

What to watch next

  1. Late December 2026

    Whether the ATDPS DOC3, planned for launch in 2026, reaches the market and begins contributing to domestic and overseas sales, to be confirmed in the revenue mix in early-2027 results.

  2. Early February 2027 (expected)

    Preliminary 2026 annual results, with timing estimated from the February 4, 2026 release of the 2025 preliminary figures. Points to watch are whether the operating margin holds in the 19% range and how profit compares with the KRW 5.91 billion of the fourth quarter of 2025.

  3. By late March 2027

    Filing of the 2026 annual report. The points to check are regional sales, non-operating items and the European subsidiary loan, along with the reason operating profit and controlling-shareholder net income diverged in 2025.

  4. Late April 2027 (expected)

    First-quarter 2027 results, with timing estimated from the April 29, 2026 release of first-quarter 2026 results. Points to check are the Suzhou subsidiary's revenue contribution, MENITH sales in northern Europe and the effect of raw-material supply.

12

Overall view

Jvmco combines automated dispensing equipment with recurring consumables, and both sales and operating profit have grown together since 2022. Sales reached KRW 173.1 billion and operating profit KRW 33.3 billion in 2025, the largest year in the period, with the operating margin holding at 19.2%.

First-quarter 2026 sales of KRW 45.5 billion and second-quarter sales of KRW 49.3 billion stayed at high levels among recent quarters, and the third-quarter operating margin reached 24.4%.

However, third-quarter sales growth slowed to 2.1% and fell from the prior quarter, so the continuity of top-line growth still needs confirmation. Net income attributable to controlling shareholders fell 1.7% in 2025, diverging from the rise in operating profit, and the last four quarters totaled KRW 34 billion.

Bullish factors include high-margin North American shipments, a low debt ratio and sales expansion plans for DOC3 and MENITH, while bearish factors include quarterly revenue swings, raw-material supply and reliance on overseas channels.

The next check points are the regional sales and income structure in the 2026 annual report and first-quarter 2027 results.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. thepublic.kr
  2. getnews.co.kr
  3. supple.kr
  4. m.ilyoweekly.co.kr
  5. hanmi.co.kr
  6. mydaily.co.kr
  7. m.news.nate.com
  8. mt.co.kr
  9. dailyinvest.kr
  10. mt.co.kr
  11. m.thinkpool.com
  12. m.news.nate.com
  13. vegannews.co.kr
  14. m.news.nate.com
  15. inthenews.co.kr
  16. m.news.nate.com
  17. digitaltoday.co.kr
  18. m.news.nate.com

Report written 2026-11-16 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis